'Meningiomics'-an Integration of Data on the Patient, Tumour, Extent of Resection and Molecular Pathology to Optimise the Management and Follow-up for Meningiomas
Overview
Authors
Affiliations
The outcomes measured and reported in intracranial meningioma clinical trials: A systematic review.
Millward C, Keshwara S, Armstrong T, Barrington H, Bell S, Brodbelt A Neurooncol Adv. 2024; 6(1):vdae030.
PMID: 38596717 PMC: 11003530. DOI: 10.1093/noajnl/vdae030.
Clinical Presentation and Prognosis.
Millward C, Keshwara S, Islim A, Zakaria R, Jenkinson M Adv Exp Med Biol. 2023; 1416:5-20.
PMID: 37432616 DOI: 10.1007/978-3-031-29750-2_2.
The clinical, genetic, and immune landscape of meningioma in patients with NF2-schwannomatosis.
Gregory G, Islim A, Hannan C, Jones A, Hammerbeck-Ward C, Rutherford S Neurooncol Adv. 2023; 5(Suppl 1):i94-i104.
PMID: 37287576 PMC: 10243851. DOI: 10.1093/noajnl/vdac127.
Millward C, Armstrong T, Barrington H, Bell S, Brodbelt A, Bulbeck H BMJ Open. 2022; 12(5):e057384.
PMID: 35534067 PMC: 9086638. DOI: 10.1136/bmjopen-2021-057384.